Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats
- PMID: 3416306
Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats
Abstract
The expression of cellular myc (c-myc) was studied during early and late stages of chemical hepatocarcinogenesis in the rat using Northern blot analysis and in situ hybridization. Hepatocarcinogenesis was induced according to the resistant hepatocyte model of Solt and Farber. An uninitiated version of this model was also used to examine the expression of c-myc during proliferation and differentiation of oval cells. The expression of c-myc was increased throughout hepatocarcinogenesis starting with early preneoplastic foci and oval cells. Similar levels of c-myc transcripts were detected in oval cells and basophilic hepatocytes generated by the uninitiated version of the protocol as were found in preneoplastic foci and oval cells during hepatocarcinogenesis. Whereas c-myc expression remained elevated in late neoplastic nodules and carcinomas, it gradually declined in both "remodelling" nodules and uninitiated livers. Our data indicate that c-myc expression is elevated during the undifferentiated stages of hepatocyte development. Furthermore, the data support the hypothesis that a critical early step in chemical hepatocarcinogenesis involves a block in the normal differentiation program of the hepatocytes.
Similar articles
-
Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat.Cancer Res. 1990 Jun 1;50(11):3439-44. Cancer Res. 1990. PMID: 1692260
-
[Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].Zhonghua Gan Zang Bing Za Zhi. 1999 Jun;7(2):110-2. Zhonghua Gan Zang Bing Za Zhi. 1999. PMID: 10488423 Chinese.
-
Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation.Cancer Res. 1989 Mar 15;49(6):1554-61. Cancer Res. 1989. PMID: 2647288
-
Molecular pathology of early stage chemically induced hepatocarcinogenesis.Pathol Int. 2009 Sep;59(9):605-22. doi: 10.1111/j.1440-1827.2009.02416.x. Pathol Int. 2009. PMID: 19712128 Review.
-
Oncogene activation and hepatocarcinogenesis.Pathobiology. 1990;58(3):153-67. doi: 10.1159/000163577. Pathobiology. 1990. PMID: 2222807 Review.
Cited by
-
Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma.Br J Cancer. 1997;76(9):1199-204. doi: 10.1038/bjc.1997.533. Br J Cancer. 1997. PMID: 9365169 Free PMC article.
-
Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.J Cancer Res Clin Oncol. 1993;119(12):737-44. doi: 10.1007/BF01195346. J Cancer Res Clin Oncol. 1993. PMID: 8104947 Free PMC article.
-
Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9577-82. doi: 10.1073/pnas.93.18.9577. Proc Natl Acad Sci U S A. 1996. PMID: 8790372 Free PMC article.
-
Characterization of liver epithelial cells transfected with myc and/or ras oncogenes.Dig Dis Sci. 1991 May;36(5):642-52. doi: 10.1007/BF01297033. Dig Dis Sci. 1991. PMID: 2022166
-
Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.Am J Pathol. 1989 Jun;134(6):1347-63. Am J Pathol. 1989. PMID: 2474256 Free PMC article. Review.